Cargando…
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients
The detection of RAS mutations and co-mutations in liquid biopsy offers a novel paradigm for the dynamic management of metastatic colorectal cancer (mCRC) patients. Expanding the results of the prospective OMITERC (OMIcs application from solid to liquid biopsy for a personalized ThERapy of Cancer) p...
Autores principales: | Lavacchi, Daniele, Gelmini, Stefania, Calabri, Adele, Rossi, Gemma, Simi, Lisa, Caliman, Enrico, Mancini, Irene, Salvianti, Francesca, Petroni, Giulia, Guidolin, Alessia, Scolari, Federico, Messerini, Luca, Pillozzi, Serena, Pinzani, Pamela, Antonuzzo, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663919/ https://www.ncbi.nlm.nih.gov/pubmed/38027900 http://dx.doi.org/10.1016/j.heliyon.2023.e21853 |
Ejemplares similares
-
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study
por: Salvianti, Francesca, et al.
Publicado: (2021) -
mCRC: rasante Weiterentwicklung zielgerichteter Therapien
por: Arnheim, Katharina
Publicado: (2022) -
ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC)
por: Masfarré, Laura, et al.
Publicado: (2021) -
Analytical Evaluation of an NGS Testing Method for Routine Molecular Diagnostics on Melanoma Formalin-Fixed, Paraffin-Embedded Tumor-Derived DNA
por: Mancini, Irene, et al.
Publicado: (2019) -
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
por: Lavacchi, Daniele, et al.
Publicado: (2022)